Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-23 Purchase |
2024-12-27 5:16 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
122,221 | $0.45 | $54,999 | 395,519 (Direct) |
View |
| 2024-09-09 Purchase |
2024-09-11 4:30 pm |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
28,856 | $0.80416 | $23,205 | 28,856 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-09 Option Award |
2024-12-10 4:51 pm |
N/A 2034-12-09 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
338,994 | $0 | 338,994 (Direct) |
View |
| 2023-10-26 Option Award |
2023-10-30 4:12 pm |
2024-10-26 2033-10-26 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
51,149 | $0 | 51,149 (Direct) |
View |
Ownership |
2023-01-03 09:40 am |
2023-04-12 2032-04-12 |
Quoin Pharmaceuticals Ltd. | QNRX | Dunn Gordon Chief Financial Officer |
0 | $0 | 357,142,800 (Direct) |
View |